123 related articles for article (PubMed ID: 24206113)
21. B-ring substituted 5,7-dihydroxyflavonols with high-affinity binding to P-glycoprotein responsible for cell multidrug resistance.
Boumendjel A; Bois F; Beney C; Mariotte AM; Conseil G; Di Pietro A
Bioorg Med Chem Lett; 2001 Jan; 11(1):75-7. PubMed ID: 11140738
[TBL] [Abstract][Full Text] [Related]
22. Calculation of polyamides melting point by quantum-chemical method and BP artificial neural networks.
Gao J; Wang X; Yu X; Li X; Wang H
J Mol Model; 2006 Mar; 12(4):521-7. PubMed ID: 16416138
[TBL] [Abstract][Full Text] [Related]
23. Image-based QSAR Model for the Prediction of P-gp Inhibitory Activity of Epigallocatechin and Gallocatechin Derivatives.
Ghaemian P; Shayanfar A
Curr Comput Aided Drug Des; 2019; 15(3):212-224. PubMed ID: 30280673
[TBL] [Abstract][Full Text] [Related]
24. Prediction of Biodegradability for Polycyclic Aromatic Hydrocarbons Using Various In Silico Modeling Methods.
Cheng G; Sun L; Fu J
Arch Environ Contam Toxicol; 2018 Nov; 75(4):607-615. PubMed ID: 30178131
[TBL] [Abstract][Full Text] [Related]
25. SAR, QSAR and docking of anticancer flavonoids and variants: a review.
Scotti L; Bezerra Mendonça Junior FJ; Magalhaes Moreira DR; da Silva MS; Pitta IR; Scotti MT
Curr Top Med Chem; 2012; 12(24):2785-809. PubMed ID: 23368103
[TBL] [Abstract][Full Text] [Related]
26. In silico prediction of dermal penetration rate of chemicals from their molecular structural descriptors.
Fatemi MH; Malekzadeh H
Environ Toxicol Pharmacol; 2012 Sep; 34(2):297-306. PubMed ID: 22659232
[TBL] [Abstract][Full Text] [Related]
27. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism.
Critchfield JW; Welsh CJ; Phang JM; Yeh GC
Biochem Pharmacol; 1994 Oct; 48(7):1437-45. PubMed ID: 7945444
[TBL] [Abstract][Full Text] [Related]
28. QSAR analysis for some diaryl-substituted pyrazoles as CCR2 inhibitors by GA-stepwise MLR.
Saghaie L; Shahlaei M; Fassihi A; Madadkar-Sobhani A; Gholivand MB; Pourhossein A
Chem Biol Drug Des; 2011 Jan; 77(1):75-85. PubMed ID: 21118376
[TBL] [Abstract][Full Text] [Related]
29. Interpretation of ANN-based QSAR models for prediction of antioxidant activity of flavonoids.
Žuvela P; David J; Wong MW
J Comput Chem; 2018 Jun; 39(16):953-963. PubMed ID: 29399831
[TBL] [Abstract][Full Text] [Related]
30. Artificial neural networks as versatile tools for prediction of MDR-modulatory activity.
Tmej C; Chiba P; Schaper KJ; Ecker G; Fleischhacker W
Adv Exp Med Biol; 1999; 457():95-105. PubMed ID: 10500785
[TBL] [Abstract][Full Text] [Related]
31. A 3D linear solvation energy model to quantify the affinity of flavonoid derivatives toward P-glycoprotein.
Boccard J; Bajot F; Di Pietro A; Rudaz S; Boumendjel A; Nicolle E; Carrupt PA
Eur J Pharm Sci; 2009 Feb; 36(2-3):254-64. PubMed ID: 18955135
[TBL] [Abstract][Full Text] [Related]
32. QSPR studies of impact sensitivity of nitro energetic compounds using three-dimensional descriptors.
Xu J; Zhu L; Fang D; Wang L; Xiao S; Liu L; Xu W
J Mol Graph Model; 2012 Jun; 36():10-9. PubMed ID: 22503858
[TBL] [Abstract][Full Text] [Related]
33. Structural contributions of substrates to their binding to P-Glycoprotein. A TOPS-MODE approach.
Estrada E; Molina E; Nodarse D; Uriarte E
Curr Pharm Des; 2010; 16(24):2676-709. PubMed ID: 20642431
[TBL] [Abstract][Full Text] [Related]
34. Quantitative structure-property relationship modelling of the degradability rate constant of alkenes by OH radicals in atmosphere.
Fatemi MH; Baher E
SAR QSAR Environ Res; 2009; 20(1-2):77-90. PubMed ID: 19343584
[TBL] [Abstract][Full Text] [Related]
35. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
Ahmadi S; Habibpour E
Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
[TBL] [Abstract][Full Text] [Related]
36. A quantitative structure-activity relationship model for radical scavenging activity of flavonoids.
Om A; Kim JH
J Med Food; 2008 Mar; 11(1):29-37. PubMed ID: 18361735
[TBL] [Abstract][Full Text] [Related]
37. Identification of Binding Sites in the Nucleotide-Binding Domain of P-Glycoprotein for a Potent and Nontoxic Modulator, the Amine-Containing Monomeric Flavonoid
Liu Z; Wong ILK; Sang J; Liu F; Yan CSW; Kan JWY; Chan TH; Chow LMC
J Med Chem; 2023 May; 66(9):6160-6183. PubMed ID: 37098275
[TBL] [Abstract][Full Text] [Related]
38. P-glycoprotein-mediated resistance to chemotherapy in cancer cells: using recombinant cytosolic domains to establish structure-function relationships.
Di Pietro A; Dayan G; Conseil G; Steinfels E; Krell T; Trompier D; Baubichon-Cortay H; Jault J
Braz J Med Biol Res; 1999 Aug; 32(8):925-39. PubMed ID: 10454753
[TBL] [Abstract][Full Text] [Related]
39. Modeling the antileishmanial activity screening of 5-nitro-2-heterocyclic benzylidene hydrazides using different chemometrics methods.
Garkani-Nejad Z; Ahmadi-Roudi B
Eur J Med Chem; 2010 Feb; 45(2):719-26. PubMed ID: 19959260
[TBL] [Abstract][Full Text] [Related]
40. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
